DECIBEL THERAPEUTICS INC - COM (DBTX)

CUSIP: 24343R106

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
17,482,679
Share change
-458,038
Total reported value
$35,836,449
Put/Call ratio
1.2%
Price per share
$2.05
Number of holders
37
Value change
-$1,797,012
Number of buys
12
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 24343R106?
CUSIP 24343R106 identifies DBTX - DECIBEL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DECIBEL THERAPEUTICS INC - COM (DBTX) as of Q4 2022

As of 31 Dec 2022, DECIBEL THERAPEUTICS INC - COM (DBTX) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,482,679 shares. The largest 10 holders included ORBIMED ADVISORS LLC, TRV GP III, LLC, BlackRock Inc., CITADEL ADVISORS LLC, Alphabet Inc., Samsara BioCapital, LLC, VANGUARD GROUP INC, BESSEMER GROUP INC, MILLENNIUM MANAGEMENT LLC, and HARVARD MANAGEMENT CO INC. This page lists 37 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.